Phaxiam Therapeutics Aktie
1,57EUR | 0,02EUR | 1,16% |
WKN DE: A3EJH8 / ISIN: FR001400K4B1
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 98,28 |
Royance Sélection Internationale | 2,20 |
Armistice Capital LLC | 1,76 |
Auriga Partners SA | 1,24 |
Afer - Flore | 0,96 |
GF Ambition Solidiaire | 0,70 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 217 | 206 | 181 | 49 | 68 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 82 | 50 | 40 | 43 | 16 |
Summe Anlagevermögen | 37 | 31 | 27 | 3 | 35 |
Summe Aktiva | 119 | 80 | 67 | 46 | 51 |
Bilanz (in Mio. EUR) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 14 | 27 | 20 | 14 | 13 |
Summe Fremdkapital | 33 | 54 | 44 | 22 | 26 |
Summe Eigenkapital | 86 | 27 | 23 | 23 | 26 |
Summe Passiva | 119 | 80 | 67 | 46 | 51 |
Adresse
60, avenue Rockefeller, 69008 Lyon | |
Telefon | +33 (4) 78-74-44-38 |
Internet | http://www.phaxiam.com |
Management
Anne-Cécile Fumey
Director-Human Resources |
Cindy Fevre
Chief Scientific Officer |
Céline Breda
Chief Technical Officer |
Didier Hoch
Chairman |
Eric Jean Marie Leire
Independent Director |
Eric Soyer
Deputy CEO, Chief Financial & Operating Officer |
Frédérique Vieville
Chief Regulatory Officer |
Gil Beyen
Vice Chairman |
Hilde Windels
Independent Director |
Jérôme Bailly
Chief Quality Officer & Deputy CEO |
Karine Charton
Chief Business Officer |
Leila Nicolas
Director |
Martine Ortin George
Independent Director |
Pascal Birman
Chief Medical Officer |
Philippe Archinard
Independent Director |
Robert Sebbag
Independent Director |
Thibaut du Fayet
Chief Executive Officer |